23 May 2013
Keywords: tarceva, approved, canada, lung, cancer, osi, pharmaceuticals
Article | 25 July 2005
OSI Pharmaceuticals of the USA says that Health Canada has cleared the use of Tarceva (erlotinib) for the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 July 2005
22 May 2013
© 2013 thepharmaletter.com